Gilead Sciences (GILD) News Today $106.50 +2.87 (+2.77%) As of 04/14/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Rossby Financial LCC Invests $232,000 in Gilead Sciences, Inc. (NASDAQ:GILD)Rossby Financial LCC purchased a new stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 2,511 shares of the biopharmaceutical company's stock, valued at approximatelyApril 15 at 6:25 AM | marketbeat.comCreativeOne Wealth LLC Buys 9,105 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)CreativeOne Wealth LLC grew its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 28.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 41,240 shares of the biopharmaceutiApril 15 at 5:54 AM | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Mariner LLCMariner LLC raised its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 6.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 550,525 shares of the biopharmaceutical company's stock after acquiriApril 15 at 5:54 AM | marketbeat.comGilead Sciences (NASDAQ:GILD) Shares Acquired Rep. Jefferson ShreveRepresentative Jefferson Shreve (R-Indiana) recently bought shares of Gilead Sciences, Inc. (NASDAQ:GILD). In a filing disclosed on April 11th, the Representative disclosed that they had bought between $15,001 and $50,000 in Gilead Sciences stock on March 31st. The trade occurred in the RepresentatApril 15 at 2:04 AM | marketbeat.comHere's What to Expect From Gilead Sciences’ Next Earnings ReportApril 15 at 12:13 AM | msn.comRep. Josh Gottheimer Buys Gilead Sciences, Inc. (NASDAQ:GILD) SharesRepresentative Josh Gottheimer (D-New Jersey) recently bought shares of Gilead Sciences, Inc. (NASDAQ:GILD). In a filing disclosed on April 10th, the Representative disclosed that they had bought between $1,001 and $15,000 in Gilead Sciences stock on March 7th. The trade occurred in the RepresentatApril 14 at 8:00 PM | marketbeat.comStamos Capital Partners L.P. Sells 19,510 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Stamos Capital Partners L.P. lessened its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 59.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 13,450 shares of the biopharmaceutical company's stApril 14 at 8:06 AM | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Stock Position Raised by Qtron Investments LLCQtron Investments LLC lifted its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 106.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,594 shares of the biopharmaceutical company's stock aftApril 14 at 6:30 AM | marketbeat.comSterling Capital Management LLC Purchases 42,040 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Sterling Capital Management LLC grew its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 747.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 47,664 shares of the biopharmaceutical company's stock afteApril 14 at 6:29 AM | marketbeat.comSagespring Wealth Partners LLC Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)Sagespring Wealth Partners LLC bought a new stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 11,940 shares of the biopharmaceutical company's sApril 14 at 5:04 AM | marketbeat.comFIL Ltd Sells 28,386 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)FIL Ltd decreased its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 69.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,467 shares of the biopharmaceutical company's stock after sellinApril 14 at 4:16 AM | marketbeat.comPetros Family Wealth LLC Makes New $271,000 Investment in Gilead Sciences, Inc. (NASDAQ:GILD)Petros Family Wealth LLC acquired a new stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 2,931 shares of the biopharmaceutical company's stock, valued at apprApril 13 at 6:34 AM | marketbeat.comLegacy Financial Advisors Inc. Takes $295,000 Position in Gilead Sciences, Inc. (NASDAQ:GILD)Legacy Financial Advisors Inc. purchased a new position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 3,198 shares of the biopharmaceutical company'April 13 at 5:58 AM | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Position Cut by Phoenix Financial Ltd.Phoenix Financial Ltd. lowered its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 76.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,945 shares of the biopharmaceutiApril 13 at 5:42 AM | marketbeat.comTrexquant Investment LP Buys New Position in Gilead Sciences, Inc. (NASDAQ:GILD)Trexquant Investment LP bought a new position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 5,658 shares of the biopharmaceutical company's stock, valued at approximaApril 13 at 4:20 AM | marketbeat.comHeritage Trust Co Buys Shares of 40,679 Gilead Sciences, Inc. (NASDAQ:GILD)Heritage Trust Co purchased a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 40,679 shares of the biopharmaceutical company's stock,April 12 at 7:43 AM | marketbeat.comKennedy Capital Management LLC Buys 16,603 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Kennedy Capital Management LLC increased its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 25.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 83,013 shares of the biopharmaceuticalApril 12 at 6:46 AM | marketbeat.comScotia Capital Inc. Grows Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Scotia Capital Inc. increased its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 9.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 162,749 shares of the biopharmaceutical company's stock afteApril 12 at 6:27 AM | marketbeat.comBessemer Group Inc. Has $8.97 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Bessemer Group Inc. grew its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 10.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 97,167 shares of the biopharmaceutical company's stock after purchasinApril 12 at 6:16 AM | marketbeat.comTreasurer of the State of North Carolina Has $59.02 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)Treasurer of the State of North Carolina lifted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 1.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 638,979 shares of the biopharmaceutical comApril 11, 2025 | marketbeat.comLSV Asset Management Sells 259,370 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)LSV Asset Management trimmed its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 4.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,028,498 shares of the biopharmaceutical company's stocApril 11, 2025 | marketbeat.comCerity Partners LLC Has $15.43 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Cerity Partners LLC trimmed its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 32.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 171,841 shares of the biopharmaceutical company's stock after selling 8April 11, 2025 | marketbeat.comGilead Sciences to Release First Quarter 2025 Financial Results on Thursday, April 24, 2025April 10, 2025 | businesswire.comGilead Sciences (NASDAQ:GILD) Shares Gap Down - What's Next?Gilead Sciences (NASDAQ:GILD) Shares Gap Down - Here's WhyApril 10, 2025 | marketbeat.comAPG Asset Management US Inc. Cuts Position in Gilead Sciences, Inc. (NASDAQ:GILD)APG Asset Management US Inc. lessened its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 11.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,728 shares of the biopharmaceutical companApril 10, 2025 | marketbeat.comMartingale Asset Management L P Lowers Position in Gilead Sciences, Inc. (NASDAQ:GILD)Martingale Asset Management L P trimmed its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 10.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 229,502 shares of the biopharmaceutical company's stock after sellingApril 10, 2025 | marketbeat.comAdvisory Services Network LLC Increases Position in Gilead Sciences, Inc. (NASDAQ:GILD)Advisory Services Network LLC boosted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 14.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 71,087 shares of the biopharmaApril 10, 2025 | marketbeat.comBank of Nova Scotia Increases Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)Bank of Nova Scotia grew its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 6.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 773,847 shares of the biopharmaceutical company's stock after purchasing an additiApril 10, 2025 | marketbeat.comMorgan Stanley Remains a Buy on Gilead Sciences (GILD)April 9, 2025 | markets.businessinsider.comMultiple Tailwinds Lifted Gilead Sciences (GILD) in Q1April 9, 2025 | finance.yahoo.comAPG Asset Management N.V. Buys 670,236 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)APG Asset Management N.V. grew its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 119.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,229,769 shares of the biopharmaceApril 9, 2025 | marketbeat.comAbacus FCF Advisors LLC Has $11.63 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Abacus FCF Advisors LLC lifted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 66.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 125,877 shares of the bApril 9, 2025 | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Position Boosted by Renaissance Technologies LLCRenaissance Technologies LLC lifted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 27.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,329,743 shares of the biopharmaceutical company'sApril 9, 2025 | marketbeat.comShelton Capital Management Has $14.37 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Shelton Capital Management trimmed its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 2.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 155,582 shares of the biopharmaceuticalApril 9, 2025 | marketbeat.comGrantham Mayo Van Otterloo & Co. LLC Has $1.21 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Grantham Mayo Van Otterloo & Co. LLC cut its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 78.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,068 shares of the biopApril 8, 2025 | marketbeat.comAnalysts Offer Predictions for Gilead Sciences Q2 EarningsGilead Sciences, Inc. (NASDAQ:GILD - Free Report) - Analysts at Zacks Research boosted their Q2 2026 earnings per share estimates for Gilead Sciences in a research note issued to investors on Friday, April 4th. Zacks Research analyst E. Bagri now forecasts that the biopharmaceutical company willApril 8, 2025 | marketbeat.comLegal & General Group Plc Trims Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)Legal & General Group Plc decreased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 18.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 9,911,231 shares of the biopharmaceutical company's stock after sellinApril 7, 2025 | marketbeat.comInvesco Ltd. Increases Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)Invesco Ltd. increased its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 12.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11,277,915 shares of the biopharmaceutical company's stock after buying an additional 1,292,399 sApril 7, 2025 | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Bought by Fmr LLCFmr LLC lifted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 21.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 40,319,432 shares of the biopharmaceutical company's stock afterApril 7, 2025 | marketbeat.comBank of Montreal Can Has $304.97 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)Bank of Montreal Can lessened its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 2.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,301,657 shares of the biopharmaceutical company's stock after selliApril 7, 2025 | marketbeat.comCertior Financial Group LLC Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)Certior Financial Group LLC acquired a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 3,572 shares of the biopharmaceutical company's stock, valued at approximateApril 7, 2025 | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Stock Position Lowered by Concentrum Wealth ManagementConcentrum Wealth Management lessened its stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 22.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 12,096 shares of the biopharmaceutical company's stock after selling 3,585 sharesApril 7, 2025 | marketbeat.comFederated Hermes Inc. Sells 688,145 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Federated Hermes Inc. trimmed its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 9.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,441,601 shares of the biopharmaceutical company's stock after selling 688,145 sharApril 7, 2025 | marketbeat.comSierra Summit Advisors LLC Boosts Stake in Gilead Sciences, Inc. (NASDAQ:GILD)Sierra Summit Advisors LLC lifted its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 67.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 23,075 shares of the biopharmaceutical companyApril 7, 2025 | marketbeat.comEnvestnet Asset Management Inc. Lowers Stake in Gilead Sciences, Inc. (NASDAQ:GILD)Envestnet Asset Management Inc. cut its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 15.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,145,658 shares of the bApril 7, 2025 | marketbeat.comZacks Research Raises Earnings Estimates for Gilead SciencesGilead Sciences, Inc. (NASDAQ:GILD - Free Report) - Equities researchers at Zacks Research lifted their Q2 2026 earnings per share estimates for shares of Gilead Sciences in a report issued on Friday, April 4th. Zacks Research analyst E. Bagri now expects that the biopharmaceutical company will eApril 7, 2025 | marketbeat.comGilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Ilmarinen Mutual Pension Insurance CoIlmarinen Mutual Pension Insurance Co lifted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 59.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 174,000 shares of the biopharmaceutApril 6, 2025 | marketbeat.comAviva PLC Sells 54,085 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)Aviva PLC trimmed its position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 4.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,094,547 shares of the biopharmaceutical company's stock aftApril 6, 2025 | marketbeat.comRhenman & Partners Asset Management AB Has $23.60 Million Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)Rhenman & Partners Asset Management AB lessened its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 30.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 255,500 shares of the biopharmaceutical company's stock afApril 6, 2025 | marketbeat.comResona Asset Management Co. Ltd. Purchases Shares of 431,022 Gilead Sciences, Inc. (NASDAQ:GILD)Resona Asset Management Co. Ltd. acquired a new position in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 431,022 shares of the biopharmaceutical company's stock, valued at appApril 6, 2025 | marketbeat.com Remove Ads Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Email Address GILD Media Mentions By Week GILD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GILD News Sentiment▼1.370.80▲Average Medical News Sentiment GILD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GILD Articles This Week▼3527▲GILD Articles Average Week Remove Ads Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AMGN News Today VRTX News Today REGN News Today ALNY News Today BIIB News Today UTHR News Today INCY News Today BMRN News Today EXEL News Today NBIX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GILD) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gilead Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GILD Stock Free GILD Stock Alerts